| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 11/04/2003 | US6642005 Method for sequencing reaction cleanup by constant pressure differential ultrafiltration |
| 11/04/2003 | US6641998 Methods and kits to enrich for desired nucleic acid sequences |
| 11/04/2003 | US6641996 Isolated nucleic acid that hybridizes to the complement of given sequence; use in drug testing and cleaving prodrugs at target site |
| 11/04/2003 | US6641819 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 |
| 11/04/2003 | US6641817 Herpes virus vectors for dendritic cells |
| 11/04/2003 | US6641812 Heat shock protein-based vaccines and immunotherapies |
| 11/04/2003 | US6641809 Method of regulating cellular processes mediated by B7 and CD28 |
| 11/04/2003 | US6641807 Helper dependent adenoviral vectors encoding erythropoietin provide high levels of epo to achieve a long-term therapeutically effective dosage, and allow for repeat administration to patients with disorders such as anaemia of |
| 11/04/2003 | CA2106377C Ethanol production by recombinant hosts |
| 11/04/2003 | CA2085191C Vaccines based on modified type 1 bovine herpesviruses |
| 11/04/2003 | CA2084677C Apo ai polypeptides, antibodies, and immunoassays |
| 11/04/2003 | CA2073616C Use of hpv-16 e6 and e7-gene derived peptides for the diagnostic purpose |
| 11/04/2003 | CA2040555C Cloned glutamic acid decarboxylase |
| 11/03/2003 | CA2427574A1 Plant bioreactor |
| 11/01/2003 | CA2391438A1 Psp94 diagnostic reagents and assays |
| 10/30/2003 | WO2003089935A1 THE METHOD FOR MEASURING THE AMOUNT OF βiG-H3 PROTEIN AND DIAGNOSTIC KIT USING THE SAME |
| 10/30/2003 | WO2003089932A1 Method for detecting the presence or risk of prostate cancer by detecting products of psa or klk2 |
| 10/30/2003 | WO2003089906A2 Functionalized nanoparticles and methods of use |
| 10/30/2003 | WO2003089903A2 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1) |
| 10/30/2003 | WO2003089901A2 Methods for preparing libraries of unique tags and related screening methods |
| 10/30/2003 | WO2003089899A2 Probes for detecting tumor cells |
| 10/30/2003 | WO2003089898A2 Determining biochemical markers of progression and therapy monitoring and specification, therapeutic lead molecules, and target biochemical systems applied to stroke |
| 10/30/2003 | WO2003089672A1 Hepatitis c virus assay systems |
| 10/30/2003 | WO2003089671A1 'doping' in walk-through mutagenesis |
| 10/30/2003 | WO2003089667A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 10/30/2003 | WO2003089650A2 Allosteric nucleic acid sensor molecules |
| 10/30/2003 | WO2003089649A1 Expression vector comprising a signal sequence and an amino-terminal peptide tag |
| 10/30/2003 | WO2003089648A1 Methods for preparing variants of a dna sequence in filamentous fungi |
| 10/30/2003 | WO2003089647A1 Xanthomonas genes associated with plant pathogenicity |
| 10/30/2003 | WO2003089646A1 Novel proteins and dnas encoding the same |
| 10/30/2003 | WO2003089645A1 Human cancer suppressor gene, hccs-4 and protein encoded therein |
| 10/30/2003 | WO2003089644A1 Novel proteins and dnas encoding the same |
| 10/30/2003 | WO2003089643A1 Novel proteins and dnas encoding the same |
| 10/30/2003 | WO2003089642A1 Oligonucleotide compositions and their use for the modulation of immune responses |
| 10/30/2003 | WO2003089640A2 Biofertilizer for plants based on rhizobium bacteria having an improved nitrogen fixing capacity |
| 10/30/2003 | WO2003089639A1 Transposon for bidirectional intramolecular genome deletions, construction of novel microorganism and identification of nonessential genes using the same |
| 10/30/2003 | WO2003089638A1 Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof |
| 10/30/2003 | WO2003089637A1 Mutation of dna polymerases from archaeobacteria |
| 10/30/2003 | WO2003089632A1 Gfp-transfected clon pig, gt knock-out clon pig and methods for production thereof |
| 10/30/2003 | WO2003089630A1 Methods for producing immortalised antibodies-secreting cells |
| 10/30/2003 | WO2003089627A1 Translocation dependent complementation for drug screening |
| 10/30/2003 | WO2003089626A1 Transgenic saccharomyces cerevisiae and method for bioremediation |
| 10/30/2003 | WO2003089624A2 Fc receptor homolog, reagents, and uses thereof |
| 10/30/2003 | WO2003089622A2 Novel genes, compositions, and methods for modulating the unfolded protein response |
| 10/30/2003 | WO2003089621A2 Promoter and plasmid system for genetic engineering |
| 10/30/2003 | WO2003089620A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 10/30/2003 | WO2003089618A2 Transposon system and methods of use |
| 10/30/2003 | WO2003089617A2 Methods for increasing homologous recombination of a nucleic acid sequence |
| 10/30/2003 | WO2003089612A2 IMPROVED rAAV VECTORS |
| 10/30/2003 | WO2003089609A2 Short fragment homologous replacement to provide bse resistant cattle |
| 10/30/2003 | WO2003089607A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 10/30/2003 | WO2003089605A2 Method of creating a library of bacterial clones with varying levels of gene expression |
| 10/30/2003 | WO2003089604A2 Methods of creating modified promoters resulting in varying levels of gene expression |
| 10/30/2003 | WO2003089603A2 Cytokine receptor |
| 10/30/2003 | WO2003089600A2 Surface transfection and expression procedure |
| 10/30/2003 | WO2003089596A2 Novel prostate tumor-specific promoter |
| 10/30/2003 | WO2003089591A2 Method of production of soluble and functional large eukaryotic proteins |
| 10/30/2003 | WO2003089589A2 Matrix analysis of gene expression in cells (magec) |
| 10/30/2003 | WO2003089587A2 Method to enhance homologous recombination |
| 10/30/2003 | WO2003089586A2 Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye |
| 10/30/2003 | WO2003089583A2 Tissue specific genes and gene clusters |
| 10/30/2003 | WO2003089580A2 Cancer models |
| 10/30/2003 | WO2003089578A2 Activation of equine oocytes |
| 10/30/2003 | WO2003089573A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 10/30/2003 | WO2003089571A2 Ehrlichia canis genes and vaccines |
| 10/30/2003 | WO2003089475A2 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 10/30/2003 | WO2003089471A1 Method for producing monoclonal antibodies |
| 10/30/2003 | WO2003089467A1 Fragments of apoptin |
| 10/30/2003 | WO2003089466A1 Novel proteins and dnas encoding the same |
| 10/30/2003 | WO2003089462A2 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
| 10/30/2003 | WO2003089458A2 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 10/30/2003 | WO2003089455A2 Low-cost production of peptides |
| 10/30/2003 | WO2003089454A2 Unnatural amino acid containing display libraries |
| 10/30/2003 | WO2003089453A2 INHIBITION OF Ii EXPRESSION IN MAMMALIAN CELLS |
| 10/30/2003 | WO2003089452A2 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase |
| 10/30/2003 | WO2003089450A2 Fusion polypeptides and methods for inhibiting microbial adhesion |
| 10/30/2003 | WO2003089137A1 System, substrate plate and incubation device for conducting biossays |
| 10/30/2003 | WO2003089136A1 Substrate plate, method and apparatus for manufacturing such a substrate plate, and system for conducting biossays comprisung such a substrate plate |
| 10/30/2003 | WO2003089011A1 rAAV VECTOR-BASED COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MAMMALIAN DISEASES |
| 10/30/2003 | WO2003088996A2 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines |
| 10/30/2003 | WO2003088995A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 10/30/2003 | WO2003088979A2 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof |
| 10/30/2003 | WO2003088925A2 Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids |
| 10/30/2003 | WO2003088921A2 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression |
| 10/30/2003 | WO2003088916A2 Compositions and methods for the acceleration of protein secretion dynamics |
| 10/30/2003 | WO2003088911A2 Universal libraries for immunoglobulins |
| 10/30/2003 | WO2003088904A2 Screening and therapeutic methods for treating circadian rhythm disorders |
| 10/30/2003 | WO2003088899A2 Methods for the production of chimeric adeno-associated virus (aav) vectors, compositions of chimeric aav vectors, and methods of use thereof |
| 10/30/2003 | WO2003088898A2 Compositions and methods for the diagnosis and treatment of tumor |
| 10/30/2003 | WO2003088812A2 Nor-1 and nur77 nuclear receptors as targets for anti-leukemia therapy |
| 10/30/2003 | WO2003088808A2 Compositions and methods for the diagnosis and treatment of tumor |
| 10/30/2003 | WO2003088738A1 Regulated ethylene sensitivity to control flower longevity in a plant |
| 10/30/2003 | WO2003073841A3 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors |
| 10/30/2003 | WO2003063725A3 Methods of preventing and treating flavivirus infection in animals |
| 10/30/2003 | WO2003059923A3 Methods and compositions for generating a genetically modified animal using lentiviral vectors |
| 10/30/2003 | WO2003057848A3 A method to maintain a genic male-sterile female parental line of wheat through selfing of the maintainer line |
| 10/30/2003 | WO2003057837A8 Methods for using anti-muc18 antibodies |
| 10/30/2003 | WO2003055989A3 Cellular compositions and methods of making and using them |
| 10/30/2003 | WO2003054161A3 USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS |
| 10/30/2003 | WO2003053365A3 Syn3 compositions and methods |